Switching from Semaglutide to Tirzepatide: Complete Guide

Why switch from semaglutide to tirzepatide?

Semaglutide (Wegovy, Ozempic) has helped millions lose weight, but a significant number of patients experience a weight loss plateau, inadequate response, or intolerable side effects. The SURMOUNT-5 trial (NEJM 2025) confirmed that tirzepatide (Zepbound, Mounjaro) produces significantly more weight loss than semaglutide in a head-to-head comparison — ~20.9% vs ~14.9% of body weight.

Common reasons for switching:

• Weight loss plateau after initial success on semaglutide
• Inadequate response — less than 5% weight loss in 3 months
• Desire for maximum efficacy — tirzepatide's dual GIP/GLP-1 mechanism produces superior results
• Side effect intolerance — some patients tolerate tirzepatide better
• Insurance or cost changes — LillyDirect vials may be cheaper than Wegovy
• New indication — Zepbound is now also approved for obstructive sleep apnea

How the switch works

There is no direct dose conversion between semaglutide and tirzepatide. They are different molecules with different mechanisms. The standard switching protocol:

1. Stop semaglutide. Take your last semaglutide dose as scheduled, then stop.
2. Washout period (1–2 weeks). Most providers recommend waiting 1–2 weeks to let semaglutide clear your system. Semaglutide has a half-life of ~1 week, so 2 weeks allows ~2 half-lives.
3. Start tirzepatide at 2.5 mg. This is the lowest starting dose, regardless of what dose of semaglutide you were on.
4. Titrate every 4 weeks. Increase by 2.5 mg every 4 weeks as tolerated: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg.
5. Monitor side effects. You may experience a recurrence of nausea or GI symptoms during the first 2–4 weeks, similar to when you first started semaglutide.

What results to expect after switching

Will I gain weight during the transition?

Most patients do not gain weight during the switch, but weight loss may slow temporarily while titrating to a therapeutic tirzepatide dose. The 2.5 mg starting dose is subtherapeutic for most adults, so appetite suppression may be weaker during weeks 1–4 compared to your maintenance semaglutide dose. Once you reach 5 mg or higher, weight loss typically resumes and often exceeds what you achieved on semaglutide.

To minimize weight regain risk during the transition:

• Maintain your dietary habits from semaglutide (protein, small meals)
• Continue regular exercise, especially resistance training
• Track your weight weekly and report any significant gain to your provider
• Avoid "catch-up eating" during the washout period

Side effects when switching

You may experience a recurrence of side effects similar to when you first started semaglutide:

• Nausea — most common, especially at dose increases. May be slightly more pronounced with tirzepatide.
• Fatigue — usually resolves within 2–4 weeks.
• GI changes — diarrhea or constipation may shift.
• Injection site reactions — tirzepatide uses a different pen device; rotate sites.

Patients who tolerated semaglutide well generally tolerate tirzepatide, though individual responses vary. If side effects are severe at any dose, contact your provider — they may slow the titration schedule.

See our complete GLP-1 side effects guide for management strategies.

Cost comparison after switching

See our GLP-1 Cost Guide 2026 for a complete pricing breakdown.

Related guides

• GLP-1 Comparison Guide 2026
• Mounjaro vs Wegovy
• Zepbound vs Wegovy
• GLP-1 Cost Guide 2026

Medical disclaimer: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before switching medications.